v3.23.3

Income Taxes | 12 Months Ended
--- | ---
Jun. 30, 2023
Income Taxes [Abstract] |
Income Taxes | 21. Income Taxes The components of the provision (benefit) for income taxes consist of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Years Ended
​ | ​ | June 30,
​ |  | 2023 |  | 2022
Current – Federal and state | ​ | $ | — | ​ | $ | —
Deferred – Federal |  | ​ | (12,153) |  | ​ | (9,051)
Deferred – State | ​ |  | (637) | ​ |  | —
Total | ​ |  | (12,790) | ​ |  | (9,051)
Change in valuation allowance | ​ |  | 12,790 | ​ |  | 9,051
Income tax expense | ​ | $ | — | ​ | $ | —
​ The Company has deferred income taxes due to income tax credits, net operating loss carryforwards, and the effect of temporary differences between the carrying values of certain assets and liabilities for financial reporting and income tax purposes. The components of the Company’s deferred tax assets and liabilities are as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | As of June 30,
​ |  | 2023 | ​ | 2022
Deferred tax assets (liabilities): | ​ | ​ | ​ | ​ | ​ | ​
Net operating loss | ​ | $ | 42,951 | ​ | $ | 35,829
Share-based compensation | ​ |  | 883 | ​ |  | 1,248
Capitalized research and development costs | ​ | ​ | 2,775 | ​ | ​ | —
Research and development tax credits | ​ |  | 1,764 | ​ |  | 1,764
Investment in equity security | ​ | ​ | 395 | ​ | ​ | 370
Property, plant and equipment | ​ | ​ | 121 | ​ | ​ | (2,520)
Intangible assets | ​ |  | (42) | ​ |  | (71)
Operating and finance lease liabilities | ​ | ​ | 1,363 | ​ | ​ | —
Operating and finance lease ROU assets | ​ | ​ | (1,184) | ​ | ​ | —
Accrued expenses | ​ |  | 529 | ​ |  | 145
Valuation allowance | ​ |  | (49,555) | ​ |  | (36,765)
Total | ​ | $ | — | ​ | $ | —
​ The Company has a valuation allowance against the full amount of its net deferred tax assets due to the uncertainty of realization of the deferred tax assets due to the operating loss history of the Company. The Company currently provides a valuation allowance against deferred taxes when it is more likely than not that some portion, or all of its deferred tax assets will not be realized. The valuation allowance could be reduced or eliminated based on future earnings and future estimates of taxable income. Federal net operating losses of approximately $5.5 million were used by the Former Parent prior to June 30, 2008 and are not available to the Company. The Former Parent allocated the use of the Federal net operating losses available for use on its consolidated Federal tax return on a pro rata basis based on all of the available net operating losses from all the entities included in its control group. U.S. federal net operating losses of approximately $202.1 million are available to the Company as of June 30, 2023, of which $63.9 million will expire at various dates through 2039 and $138.2 million with no expiration date. These carryforwards could be subject to certain limitations in the event there is a change in control of the Company pursuant to Internal Revenue Code Section 382, though the Company has not performed a study to determine if the loss carryforwards are subject to these Section 382 limitations. The Company has a research and development credit carryforward of approximately $1.76 million at June 30, 2023. In addition, the Company has net operating loss carry forwards from various states of approximately $35.2 million which expire from 2029 through 2042. A reconciliation of the statutory tax rate to the effective tax rate is as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Years Ended
​ | ​ | June 30,
​ |  | 2023 | ​ | 2022
Statutory federal income tax rate |  | 21 | % | ​ | 21 | %
State taxes, net of federal benefit |  | 1 | % | ​ | — | %
Expiration and forfeiture of stock options | ​ | (2) | % | ​ | — | %
Change related to iBio CDMO |  | — | % | ​ | (3) | %
Change in valuation allowance |  | (20) | % | ​ | (18) | %
Effective income tax rate |  | — | % | ​ | — | %
​ The Company has not been audited in connection with income taxes. iBio files U.S. Federal and state income tax returns subject to varying statutes of limitations. The 2019 through 2022 tax returns generally remain open to examination by U.S. Federal authorities and by state tax authorities.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//740/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration